FDA NDC Directory · JSON-LD · Markdown

Bumetanide

NDC 69238-1489 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAmneal Pharmaceuticals NY LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA209724
Dosage form / routeTABLET · ORAL
Active ingredientsBUMETANIDE (.5 mg/1)
Marketing started20171018
Package count2

External sources

Source: openFDA. Public-domain (CC0).